BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10631814)

  • 1. The vimentin promoter as a tool to analyze the early events of retinoic acid-induced differentiation of cultured embryonal carcinoma cells.
    Benazzouz A; Duprey P
    Differentiation; 1999 Nov; 65(3):171-80. PubMed ID: 10631814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of the cellular retinoic acid binding protein I gene in F9 teratocarcinoma cells.
    Means AL; Thompson JR; Gudas LJ
    Cell Growth Differ; 2000 Feb; 11(2):71-82. PubMed ID: 10714763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of the murine Elf3 gene in embryonal carcinoma cells and their differentiated counterparts: requirement for a novel upstream regulatory region.
    Hou J; Wilder PJ; Bernadt CT; Boer B; Neve RM; Rizzino A
    Gene; 2004 Sep; 340(1):123-31. PubMed ID: 15556300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The function of inducible promoter systems in F9 embryonal carcinoma cells.
    Miller K; Rizzino A
    Exp Cell Res; 1995 May; 218(1):144-50. PubMed ID: 7737354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive expression of the Wilms tumor suppressor gene WT1 in F9 embryonal carcinoma cells induces apoptotic cell death in response to retinoic acid.
    Kudoh T; Ishidate T; Nakamura T; Toyoshima K; Akiyama T
    Oncogene; 1996 Oct; 13(7):1431-9. PubMed ID: 8875981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of upstream regulatory elements that repress expression of adult beta-like globin genes in a primitive erythroid environment.
    Ebb D; Tang DC; Drew L; Chin K; Berg PE; Rodgers GP
    Blood Cells Mol Dis; 1998 Sep; 24(3):356-69. PubMed ID: 10087993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A putative G-protein-coupled receptor, H218, is down-regulated during the retinoic acid-induced differentiation of F9 embryonal carcinoma cells.
    Li Y; MacLennan AJ; Rogers MB
    Exp Cell Res; 1998 Mar; 239(2):320-5. PubMed ID: 9521849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic footprinting of retinoic acid regulated promoters in embryonal carcinoma cells.
    Dey A; Ozato K
    Methods; 1997 Feb; 11(2):197-204. PubMed ID: 8993032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroidogenic factor 1-dependent promoter activity of the human steroidogenic acute regulatory protein (StAR) gene.
    Sugawara T; Holt JA; Kiriakidou M; Strauss JF
    Biochemistry; 1996 Jul; 35(28):9052-9. PubMed ID: 8703908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the human MSX-1 promoter and an enhancer responsible for retinoic acid induction.
    Shen R; Chen Y; Huang L; Vitale E; Solursh M
    Cell Mol Biol Res; 1994; 40(4):297-312. PubMed ID: 7866431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The murine Hoxb1 3' RAIDR5 enhancer contains multiple regulatory elements.
    Thompson JR; Huang DY; Gudas LJ
    Cell Growth Differ; 1998 Dec; 9(12):969-81. PubMed ID: 9869297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of the int-2 gene in embryonal carcinoma cells.
    Grinberg D; Thurlow J; Watson R; Smith R; Peters G; Dickson C
    Cell Growth Differ; 1991 Mar; 2(3):137-43. PubMed ID: 1647813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for p21 (WAF1) in the cAMP-dependent differentiation of F9 teratocarcinoma cells into parietal endoderm.
    Drdová B; Vachtenheim J
    Exp Cell Res; 2005 Mar; 304(1):293-304. PubMed ID: 15707594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of retinoic acid receptor activity associated with decreased alpha and gamma isoforms expression in F9 embryonal carcinoma cells differentiated by retinoic acid.
    Lazega D; Schenker E; Busso N; Zelent A; Chen A; Waxman S
    J Cell Physiol; 1993 Oct; 157(1):90-6. PubMed ID: 8408246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cis-regulatory elements and transcription factors involved in the regulation of the transforming growth factor-beta 2 gene.
    Scholtz B; Kelly D; Rizzino A
    Mol Reprod Dev; 1995 Jun; 41(2):140-8. PubMed ID: 7654367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of early growth-associated events during the differentiation of F9 cells into embryoid bodies.
    Whitman MM; Shen YM; Soprano D; Soprano KJ
    Cancer Res; 1990 Jun; 50(11):3193-8. PubMed ID: 2139801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
    Chuĭkin IA; Lianguzova MS; Pospelov VA
    Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Wnt-13 is developmentally regulated during the differentiation of NTERA-2 pluripotent human embryonal carcinoma cells.
    Wakeman JA; Walsh J; Andrews PW
    Oncogene; 1998 Jul; 17(2):179-86. PubMed ID: 9674702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of mouse Disabled 2 gene in retinoic acid-treated F9 embryonal carcinoma cells and early mouse embryos.
    Cho SY; Cho SY; Lee SH; Park SS
    Mol Cells; 1999 Apr; 9(2):179-84. PubMed ID: 10340473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.